Cervix cancer radiotherapy: Treatment and outcome

The group focus on the entire process of radiotherapy for cervix cancer including imaging, treatment planning, treatment delivery and patient outcome.

Go to

Professor of medical physics
Kari Tanderup
karitand@rm.dk

Further information.

Postdoc
Monica Serban
monica.serban@oncology.au.dk.
PURE, Aarhus University.

Postdoc
Marta Pelizzola
marta.pelizzola@rm.dk

PhD Student
Mayuri Charnalia
msc@oncology.au.dk

Development of the EMBRACE III studies, Kari Tanderup, Aarhus University Hospital, Remi Nout Erasmus MC University Medical Center, Netherlands, Max Schmid, Medical University of Vienna, Austria
Risk factors for development of side effects and decreased quality of life after radiotherapy in cervix cancer, Sofia Spampinato, Aarhus University Hospital
Characterisation of cervix cancer radiotherapy treatment parameters and correlation to development of side effects, Monica Serban, McGill University, Montreal, Canada
Quality of life, patient reported symptoms, side effects and sexuality after cervix cancer radiotherapy, Kathrin Kirchheiner, Medical University of Vienna, Austria
Burden and severity of side effects after cervix cancer radiotherapy, Supriya Chopra, Tata Memorial Cancer Center, Mumbai, India
Treatment of oligometastatic disease and outcome of salvage treatment in cervix cancer, Lars Fokdal, Aarhus University Hospital, Supriya Chopra, Tata Memorial Cancer Center, Mumbai, India
Prognostic markers for disease outcome and survival in locally advanced cervix cancer, Jacob Lindegaard, Aarhus University Hospital, Umesh Mahantshetty, Tata Memorial Cancer Center, India, Max Schmid, Medical University of Vienna, Austria
Fatigue after cervix cancer radiotherapy, Stephanie Smet, University of Leuven, Belgium
Proton therapy in locally advanced cervix cancer, Lars Fokdal, Aarhus University Hospital, Remi Nout, Erasmus MC University Medical Center, Netherlands
Education and effects of teaching and training, Simon Duke and Li Tee Tan, Cambridge University Hospital, UK
Image guided adaptive brachytherapy in primary and recurrent vaginal cancer (EMBRACE study), Lars Fokdal, Aarhus University Hospital, Max Schmid, Medical University of Vienna, Austria, Henrike westerveld Department of Radiotherapy, AMC The Netherlands, Remi Nout, Erasmus MC University Medical Center, Netherlands

Cervix cancer radiotherapy: Treatment and outcome

Projects and collaborating partners